Sponsored Insight Hogan Lovells A data-driven era: Why digital tools are critical to life sciences players
Sponsored Insight Hogan Lovells Foreign device manufacturers should anticipate greater chance of FDA inspection under new FDA leadership
Sponsored Insight Hogan Lovells Measures of success: How value-based pricing may change the pharmaceutical industry
Sponsored Insight Hogan Lovells Lower regulatory barriers may accelerate innovation for drug and device manufacturers
Sponsored Insight Hogan Lovells What’s in store for the Affordable Care Act and drug pricing policy under the Trump administration?
Sponsored Insight Hogan Lovells In the EU, drug and device design can influence acceptance and pricing
Sponsored Insight Hogan Lovells The FDA feels the pain in a court decision about promoting prescription drugs
Sponsored Insight Hogan Lovells Mobile medical apps are a form of medical device — and are regulated as such
Sponsored Insight Hogan Lovells The market for biosimilars is growing in spite of unanswered questions
